Rheumatology Partner Buyout Financing
A rheumatology partner buyout happens when one or more owners purchase the interest of a partner who is retiring, relocating, changing careers or otherwise leaving the practice. In small rheumatology groups, where a few physicians may share ownership of the clinic, the infusion program and sometimes the building, a partner’s departure can be a major financial event.
Financing can help the remaining partners complete the purchase without draining the practice’s cash. This article covers how buyouts are often structured, how the price may be determined and what lenders review. Partnership agreements, ownership rules and tax treatment vary, and nothing here is legal, tax, billing or compliance advice.
Start With the Partnership Agreement
Most groups have an operating or partnership agreement that addresses what happens when a partner leaves. It may set out:
- The events that trigger a buyout, such as retirement, disability or voluntary departure
- How the departing partner’s interest will be valued
- Whether payment is made at closing or over time
- Restrictive covenants or notice requirements
- How interests in affiliated entities, such as infusion or real estate, are handled
If the agreement is silent or outdated, the partners will need to negotiate terms. Counsel should review the agreement before any buyout is finalized.
Valuing the Departing Partner’s Interest
In a rheumatology partner buyout, the value of the departing interest may include a share of hard assets, accounts receivable, drug inventory, the infusion and imaging programs and goodwill. Some agreements use a set formula, while others call for an independent valuation.
Infusion revenue deserves particular attention. Drug margins can change with payer policies and biosimilar adoption, so a valuation based on past infusion profits may not reflect future earnings. Our article on rheumatology practice valuation explains how these factors are often assessed. Our advisory and consulting services can also help partners think through succession and valuation questions.
Who Buys the Interest
A departing partner’s interest may be purchased by:
- The remaining partners individually: each buys a portion of the interest
- The practice entity: the practice redeems the interest, reducing the number of owners
- A new partner: an associate buys in to replace the departing owner
- A combination: for example, partial redemption plus a new partner buy-in
The structure can affect taxes, financing and future ownership, so it should be reviewed with counsel and an accountant. If a new physician is joining, our article on financing a rheumatology practice buy-in covers that side of the transaction.
Financing Options for a Rheumatology Partner Buyout
Depending on the structure and the practice, options may include:
- SBA 7(a) loans: SBA 7(a) loans can be used for certain partner buyouts in some cases, and eligibility and terms depend on the business, the borrowers, use of proceeds, program rules on changes of ownership and lender review
- Conventional practice loans: conventional practice loans follow the lender’s own standards and may suit groups with strong financial history
- Payments to the departing partner over time: a note to the departing partner, which is typically subordinate to any senior loan and may be limited by the lender or program
Every loan is subject to approval, and nothing here is a commitment to lend. Lenders and programs may also limit earnouts or contingent payments, so those terms should be discussed early.
What Lenders Review
Lenders evaluating a buyout loan typically look at:
- The practice’s tax returns and financial statements
- The partnership agreement and proposed buyout terms
- The valuation or formula used to set the price
- The remaining partners’ credit, experience and personal finances
- How the departing partner’s patients will be covered
- Infusion revenue, drug margins and payer mix
The key question is often whether the practice can maintain revenue and cover the new debt after the partner leaves.
Planning for Patient Coverage
When a partner leaves, their patients need continued care. Lenders and remaining partners will want to know how that will happen. Options include redistributing patients among remaining physicians, adding an advanced practice provider or recruiting a new rheumatologist. A plan that keeps patients in the practice helps protect the revenue that supports the buyout.
Real Estate and Affiliated Entities
If the departing partner owns a share of the building or an affiliated entity, those interests may be bought out separately. Some groups handle the practice buyout first and the real estate later. Each piece may have its own valuation and financing approach, and structures involving ancillary services should be reviewed by healthcare counsel.
Avoiding Common Problems
- Relying on an outdated partnership agreement or formula
- Overlooking the cash needed to cover the departing partner’s share of receivables or inventory
- Failing to plan patient coverage before the departure date
- Agreeing to payment terms that strain the practice’s cash flow
- Waiting until the last minute to talk with a lender
Timing and Communication
Partner departures often go more smoothly when they are planned well in advance. Giving the group time to recruit, arrange financing and notify patients can reduce disruption. Staff and referring physicians also benefit from clear, consistent communication about who will provide care going forward.
Partners can prepare by reviewing the agreement together, gathering financial records, obtaining a valuation if needed and speaking with a lender before the departure date is set. Early planning gives the group more options and makes it less likely that a buyout will be rushed.
When a Buyout Becomes a Sale
Sometimes the remaining partners decide not to buy out the departing interest and instead consider selling the entire practice. If that is under discussion, our article on how to sell a rheumatology practice covers preparation and buyer types.
Final Thoughts
A rheumatology partner buyout can preserve a group’s independence and continuity when a physician leaves. Clear agreements, a realistic valuation, a patient coverage plan and the right financing structure can help the remaining partners move forward with confidence.
US Medical Funding helps rheumatology groups finance partner buyouts and ownership transitions. Learn more about our rheumatology practice acquisition financing.



